Principal Investigators

Dr. Mohammad Yunus, MD, MSc (PI U01) : Dr. Yunus currently holds the position of Emeritus Scientist at icddr,b. He has years of experience in developing and conducting scientific research as principal investigator and co-investigator. He was the Head of icddr,b Matlab Health Research Centre and a Senior Scientist. He has been actively involved in clinical and epidemiological research on diarrheal disease and nutrition and other public health issues. He was also involved in the study of prevalence of Chronic Obstructive Pulmonary disease (COPD) and its risk factors in adults in rural and urban Bangladesh. He has over three decades of research experience in the field of diarrheal diseases, nutrition, arsenic and health effects including cancer, priority environmental and occupational public health concerns, and other aspects of public health. He is leading the research component (U01) project and guiding the research team in implementing the study. Dr. Yunus is also working with his developed country partner Dr. Ahsan in achieving the overall goal of the U01/U2R paired projects.


Professor Habibul Ahsan, M.D., MMedSc. (PI U2R) : Dr. Habibul Ahsan is a Professor of department of Public Health Sciences and associate director of cancer research center at University of Chacago, USA. Dr. Ahsan’s research interests focus on the interplay between environmental and genetic factors in cancer and exploiting this information in cancer prevention in humans. He published extensively on the molecular epidemiology of carcinogenic effects of arsenic exposure and also on the molecular and genetic epidemiology of hormonal etiology of breast cancer. His ongoing NIH-funded major research projects include: 1) a genome-wide association study to identify novel genes for early-onset breast cancer among 6,000 breast cancer cases and population/sister controls; 2) a prospective cohort study of 15,000 men and women in Bangladesh to investigate the intermediate- and long-term carcinogenic effects of environmental arsenic exposure from drinking water; 3) genetic susceptibility to arsenic-induced pre-malignant skin lesions and skin cancers among 3,000 cases and controls; and 4) a randomized clinical trial of vitamin E and selenium among 6,000 individuals with pre-malignant skin lesions for the prevention of cancers and deaths. He is leading the training component (U2R). Dr. Ahsan is also working with his developing country partner Dr. Yunus in achieving the overall goal of the U01/U2R paired projects.